Literature DB >> 2789044

Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factor.

B Everaerdt1, P Brouckaert, A Shaw, W Fiers.   

Abstract

We studied the induction of lethal shock by Tumour Necrosis Factor (TNF) in mice and observed a remarkable difference between the effect of human and murine TNF, which could be eliminated by co-administration of sensitizing agents. We identified interleukin-1 (IL1) as a natural sensitizer, rendering mice as susceptible to human TNF as to murine TNF. This IL1 activity was found to be exerted to the same extent both by human and murine IL1-alpha or IL1-beta, and was also different from the sensitization obtained with galactosamine, since these agents had an additive effect. Pretreatment of the animals with indomethacin, a cyclooxygenase inhibitor, provided partial protection against TNF lethality in IL1-sensitized but not in galactosamine-sensitized mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789044     DOI: 10.1016/0006-291x(89)92146-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Myeloid-derived NF-κB negative regulation of PU.1 and c/EBP-β-driven pro-inflammatory cytokine production restrains LPS-induced shock.

Authors:  Simone Vanoni; Yi-Ting Tsai; Amanda Waddell; Lisa Waggoner; Jared Klarquist; Senad Divanovic; Kasper Hoebe; Kris A Steinbrecher; Simon P Hogan
Journal:  Innate Immun       Date:  2016-12-08       Impact factor: 2.680

2.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion.

Authors:  L Shapira; W A Soskolne; Y Houri; V Barak; A Halabi; A Stabholz
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

3.  Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.

Authors:  M Machnicki; M Zimecki; T Zagulski
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

4.  Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.

Authors:  L S Rusten; E B Smeland; F W Jacobsen; E Lien; W Lesslauer; H Loetscher; C M Dubois; S E Jacobsen
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

5.  Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice.

Authors:  H Heremans; J Van Damme; C Dillen; R Dijkmans; A Billiau
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

6.  Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma.

Authors:  P Vandenabeele; W Declercq; D Vercammen; M Van de Craen; J Grooten; H Loetscher; M Brockhaus; W Lesslauer; W Fiers
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

7.  Neutral endopeptidase modulation of septic shock.

Authors:  B Lu; N P Gerard; L F Kolakowski; M Bozza; D Zurakowski; O Finco; M C Carroll; C Gerard
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

8.  A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis.

Authors:  Yi Ma; Shaojun Zhao; Shutao Shen; Shixiong Fang; Zulu Ye; Zhi Shi; An Hong
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.